Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MASeptember 16, 2024 8:00 AM EDT | Source: Phio Pharmaceuticals Corp.Phio's INTASYL self-delivering RNAi technology enhances cell potency and yield in Adoptive Cell Therapy Marlborough, Massachusetts--(Newsfile Corp. - September 16, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune c ...